LifeLens Technologies

LifeLens Technologies, Inc. is a company that develops physiologic monitoring products aimed at transforming telemedicine and remote therapeutic practices. The company's main product is the LifeLens Wireless ECG Monitor, which is designed for patients 18 years or older who may be asymptomatic or experience transient symptoms such as palpitations, shortness of breath, dizziness, light-headedness, pre-syncope, syncope, fatigue, chest pain, and anxiety. As of 2023, the LifeLens Wireless ECG Monitor was not intended for use during defibrillation and was not FDA cleared for indications beyond those mentioned.

In addition to its consumer-focused products, LifeLens Technologies has developed the Ascent Platform, a wearable physiological sensor system for military applications. This platform was successfully demonstrated at the Army Expeditionary Warrior Experiment (AEWE) at Fort Benning in spring 2021. During this event, the Ascent Platform captured data from 48 soldier-missions, collecting over 60 metrics from each soldier without any field failures. The company's technology aims to provide wearability and comfort while delivering high-quality, multichannel data with powerful recording, analysis, storage, and real-time telemetry capabilities.

LifeLens Technologies' focus is on creating easy-to-use physiologic monitoring products that can be applied in various military and consumer scenarios. As of June 2021, the company employed 31 staff members with expertise directly contributing to their technological development efforts.